Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPCB | AMGN | BMY | GILD | VRTX |
| Company | Propanc Biopharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0010 | 265.72 | 44.68 | 65.50 | 393.52 |
| High | 0.0011 | 271.68 | 45.37 | 66.35 | 399.68 |
| Low | 0.0010 | 265.72 | 44.34 | 64.63 | 393.49 |
| Last | 0.0010 | 270.86 | 45.12 | 65.57 | 398.27 |
| Change | -0.0001 | +1.48 | +0.42 | +0.30 | +0.57 |
| % Change | -9.09% | +0.55% | +0.94% | +0.46% | +0.14% |
| Volume | 1,843,390 | 837,220 | 10,076,662 | 7,608,801 | 288,555 |
| 20-Day Average Volume | 5,574,104 | 2,072,988 | 12,626,597 | 6,814,843 | 923,060 |
| Previous Close | 0.0011 | 269.38 | 44.70 | 65.27 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0015 | 270.03 | 49.49 | 68.30 | 401.33 |
| 20-Day Raw Stochastic | 0.00% | 43.56% | 8.70% | 11.55% | 24.79% |
| 20-Day Relative Strength | 36.91% | 46.35% | 31.03% | 30.39% | 43.48% |
| Weighted Alpha | -96.44 | +9.91 | -33.70 | -23.16 | +15.21 |
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 56% Sell | 40% Buy | 8% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.09% since 04/19/24 | +0.70% since 04/19/24 | -7.62% since 04/19/24 | -1.70% since 04/19/24 | +1.08% since 04/19/24 |
| Low | 0.0010 on 04/26/24 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 |
| High | 0.0015 on 04/22/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -62.96% since 03/26/24 | -3.89% since 03/26/24 | -13.99% since 03/26/24 | -9.37% since 03/26/24 | -4.76% since 03/26/24 |
| Low | 0.0010 on 04/26/24 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 0.0045 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -81.48% since 01/26/24 | -13.14% since 01/26/24 | -9.05% since 01/26/24 | -17.48% since 01/26/24 | -7.35% since 01/26/24 |
| Low | 0.0010 on 04/26/24 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
| High | 0.0068 on 01/30/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -92.81% since 10/26/23 | +0.40% since 10/26/23 | -14.67% since 10/26/23 | -16.40% since 10/26/23 | +10.32% since 10/26/23 |
| Low | 0.0010 on 04/26/24 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
| High | 0.0210 on 11/14/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 57 | 144,488,960 | 90,596,128 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 52,145 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -2,660,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -580,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.74 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 02/20/24 | 4.71 on 02/06/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 6.51 | 9.98 | 29.82 |